← Leaderboards
Diane M Cibrik
University Of Kansas Medical Center
$349,240
Attributed
$659,240
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $310K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$659,240 · 3
By mechanism
R01$620,000 · 1
M01$39,240 · 2
Top collaborators
- John M Jakicic2 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- John M Jakicic$37,725,863
- Carolyn R Bates$623,586
Others in their field
Top investigators on “Kidney Transplantation”
- Peter Scott Heeger · Case Western Reserve University$86,758,000
- Joren C Madsen · Massachusetts General Hospital$51,129,981
- Dorry Segev · Johns Hopkins University$40,143,271
- Peter G Stock · University Of California San Francisco$37,405,503
- Robert M Merion · University Of Michigan At Ann Arbor$29,566,275
- John C Magee · University Of Michigan At Ann Arbor$28,786,531
Research focus
Kidney TransplantationDiabetes MellitusAreaAdverse OutcomeBody WeightBody Weight DecreasedBiological MarkersCyclosporinesCaringClinical ResearchClinical TreatmentClinical TrialsCombination MedicationConduct Clinical TrialsCost Effectiveness AnalysisCardiometabolic DiseaseAdipose TissueCardiometabolismDietDietaryDietary InterventionEffectivenessEnd Stage Renal FailureEnergy Balance
Grant awards (7)
Prevention of Weight Gain and Impaired Glucose Metabolism Post Kidney Transplantation: A Pilot and Feasibility Study$310,000
R01 · FY2025 · DK
Prevention of Weight Gain and Impaired Glucose Metabolism Post Kidney Transplantation: A Pilot and Feasibility Study$310,000
R01 · FY2024 · DK
RELATIVE VARIABILITY OF PROGRAF, NEORAL & CELLCEPT IN DIABETIC KIDNEY TXT PTS$3,066
M01 · FY2006 · RR · contact PI
RELATIVE VARIABILITY OF PROGRAF, NEORAL &CELLCEPT IN DIABETIC KIDNEY TXT PTS$5,662
M01 · FY2005 · RR
BLINDED NEORAL C2 MONITORING IN DE NOVO RENAL TRANSPLANT RECIPIENTS$1,030
M01 · FY2005 · RR
Relative Variability of Prograf, Neoral &Cellcept in Diabetic Kidney Txt Pts$17,791
M01 · FY2004 · RR
Blinded Neoral C2 Monitoring in De Novo Renal Transplant Recipients$11,691
M01 · FY2004 · RR